Issues
- Current Issue
- Special Issues
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Search

ASH Home
About ASH Clinical News
Authors
Advertising
Subscribe
Contact Us
eNewsletters

Cookie Settings

LOG IN

Welcome! Log into your account

Forgot your password?

Recover your password

ASH Clinical News

Issues
- All Current Issue Special Issues
  
  April 2021 Volume 7 Issue 5
  
  March 2021 Special Edition
  
  March 2021 Volume 7 Issue 4
  
  February 2021 Volume 7 Issue 3
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Generic selectors

Exact matches only

Exact matches only

Search in title

Search in title

Search in content

Search in content

Search in excerpt

Search in posts

Search in posts

Search in pages

Search in pages

Peter Hokland, MD, DMedSci

Peter Hokland, MD, DMedSci

Clinical professor in the department of hematology at Aarhus University in Denmark

Advertisement

Current Issue

April 2021 Volume 7 Issue 5

Thursday, April 1, 2021

This issue examines long-haul COVID-19, central nervous system relapse in non-Hodgkin lymphoma, and more.

Block title

New Children’s Hospital Coalition Aims to Combat Pandemic-Driven Drug Shortages

Thursday, April 15, 2021

Study Finds Children with Down Syndrome Have Higher Risk of AML

Thursday, April 15, 2021

Biden Administration Proposes $6.5 Billion Health Research Agency

Thursday, April 15, 2021

European Commission Approves Selinexor Plus Dexamethasone for Relapsed/Refractory Myeloma

Sunday, April 11, 2021

FDA Approves Isatuximab-irfc Combination for Relapsed/Refractory Myeloma

Sunday, April 11, 2021

Recent Posts

New Children’s Hospital Coalition Aims to Combat Pandemic-Driven Drug Shortages
Study Finds Children with Down Syndrome Have Higher Risk of AML
Biden Administration Proposes $6.5 Billion Health Research Agency
European Commission Approves Selinexor Plus Dexamethasone for Relapsed/Refractory Myeloma

Meeting Coverage

Researchers Validate Burkitt Lymphoma Prognostic Index

Monday, March 1, 2021

Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

Monday, March 1, 2021

Editor's Corner

Editor’s Corner: Post-Pandemia Mania

Thursday, April 1, 2021

Editor’s Corner: Healing Our Invisible Wounds

Monday, March 1, 2021

2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright © 2020 by American Society of Hematology

Contact Us | Terms of Service | Privacy Policy